David J. Adelstein

An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer

David J. Adelstein, Yi Li, George L. Adams et al. · Journal of Clinical Oncology · 2002 · 1.7K citations

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

David G. Pfister, Sharon Spencer, David J. Adelstein et al. · Journal of the National Comprehensive Cancer Network · 2020 · 1.3K citations

Cancer Management, Pathology, Oncology +19

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison, Andy Trotti, Jonathan Harris et al. · The Lancet · 2018 · 1.2K citations

Radiation Therapy, Medicine, Nasopharyngeal Cancer +8

Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

Thomas P. Miller, Steve Dahlberg, J. Robert Cassady et al. · New England Journal of Medicine · 1998 · 1K citations · Full text

Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study

Brian O’Sullivan, Shao Hui Huang, Jie Su et al. · The Lancet Oncology · 2016 · 730 citations

Cancer-associated Virus, Oropharyngeal Cancer Network, International Collaboration +10